| CORPORATE PRESENTATION | ||
| Corporate Presentation (September 2023) |  |
|
| 2023 | WEBCAST | ||
| 4 Aug 2023 | H1 FY2023 Financial Results | |
 |
| 20 Jul 2023 | Acquisition of Idorsia’s Pharmaceuticals Business in Japan and APAC (ex China) | |
|
| 23 Mar 2023 | 33rd Ordinary General Meeting of Shareholders | |
|
| 15 Mar 2023 | Top Interview - Stock Voice TV (Japanese only) | |
|
| 14 Feb 2023 | FY2022 Financial Results Presentation | |
|
| 11 Jan 2023 | 41st J.P. Morgan Healthcare Conference | |
|
| 2022 | WEBCAST | ||
| 15 Nov 2022 | Jefferies London Healthcare Conference | |
|
| 25 Oct 2022 | IR seminar for individual investors (Japanese only) - Sosei's Business Overview | |
|
| 13 Oct 2022 | R&D Day | |
|
| 4 Oct 2022 | IR seminar for individual investors (Japanese only) - Intrroduction for Biotechnology Sector | |
|
| 10 Aug 2022 | H1 FY2022 Financial Results Presentation | |
|
| 24 Mar 2022 | 32nd Ordinary General Meeting of Shareholders | |
|
| 10 Feb 2022 | FY2021 Financial Results Presentation | |
|
| 10 Jan 2022 | 40th Annual J.P. Morgan Healthcare Conference | |
|
| 2021 | WEBCAST | ||
| 24 Nov 2021 | Investor Webinar Q&A - Collaboration with Neurocrine Biosciences to Develop Novel Muscarinic Receptor Agonists | |
|
| 22 Nov 2021 | Collaboration with Neurocrine Biosciences to Develop Novel Muscarinic Receptor Agonists | |
|
| 16 Nov 2021 | Jefferies London Healthcare Conference 2021 Presentation | |
|
| 12 Aug 2021 | H1 FY2021 Financial Results Presentation | |
|
| 25 May 2021 | UBS Global Healthcare Virtual Conference 2021 | |
|
| 26 Mar 2021 | Online briefing session for investors (in Japanese) | |
|
| 24 Mar 2021 | 31st Ordinary General Meeting of Shareholders | |
|
| 15 Feb 2021 | FY2020 Financial Results Conference Call | |
|
| 12 Feb 2021 | FY2020 Financial Results Presentation | |
|
| 14 Jan 2021 | 39th Annual J.P. Morgan Healthcare Conference | |
|
| 5 Jan 2021 | Regains Muscarinic Agonist Programs | |
|
| 2020 | WEBCAST | ||
| 20 Nov 2020 | Coronavirus Program Update | |
|
| 13 Aug 2020 | H1 FY2020 Financial Results Presentation | |
|
| 25 Jun 2020 | New Discovery Collaboration With AbbVie (Japanese only) | ||
| 25 Mar 2020 | 30th Ordinary General Meeting of Shareholders | |
|
| 17 Feb 2020 | FY2019 Financial Results Presentation | |
|
| 15 Jan 2020 | 38th Annual J.P. Morgan Healthcare Conference | |
|
| ARCHIVE | WEBCAST | ||
| 12 Sep 2019 | Investor R&D Day Presentation - Malcolm Weir, EVP Chief R&D Officer | ||
| 12 Sep 2019 | Investor R&D Day Presentation - Chris de Graaf Director, Head of Computational Chemistry | ||
| 12 Sep 2019 | Investor R&D Day Presentation - Stacey Southall Associate Director, Head of Biophysics | ||
| 12 Sep 2019 | Investor R&D Day Presentation - Rie Suzuki - Director, Translational Sciences | ||
| 12 Sep 2019 | Investor R&D Day Presentation - Professor Yoshinori Fujiyoshi (Japanese Only) | ||
| 12 Sep 2019 | Investor R&D Day Webcast | |
|
| 13 Aug 2019 | H1 FY2019 Financial Results Presentation | |
|
| 18 Jun 2019 | Individual Shareholders Briefing (Japanese only) | ||
| 27 Mar 2019 | 29th Ordinary General Meeting of Shareholders | |
|
| 22 Feb 2019 | Individual Shareholders Briefing (Japanese only) | ||
| 12 Feb 2019 | FY2018 Financial Results (Nine-month period ended December 31, 2018) Presentation (with note) | |
|
| 12 Feb 2019 | FY2018 Financial Results (Nine-month period ended December 31, 2018) Presentation | |
|
| 4 Feb 2019 | New collaboration deal with Medicxi | ||
| 7 Jan 2019 | 37th Annual J.P. Morgan Healthcare Conference (Presentation Transcript) | |
|
| 8 Nov 2018 | FY2018 Q2 Results Presentation (with note) | |
|
| 8 Nov 2018 | FY2018 Q2 Results Presentation | |
|
| 18 Sep 2018 | Update on development activities with HTL0018318 | |
|
| 22 Jun 2018 | 28th Ordinary General Meeting of Shareholders | |
|
| 21 May 2018 | 2018 UBS Global Healthcare Conference | |
|
| 6 Aug 2018 | Corporate Profile Full Year Ended 31 Mar 2018 | |
|
| 10 May 2018 | FY2017 Full Year Results Presentation | |
 |
| 14 Mar 2018 | 2018 Investor Day WEBCAST Opening Remarks by Peter Bains, CEO | |
|
| 14 Mar 2018 | 2018 Investor Day WEBCAST, Pipeline Update by Dr Malcolm Weir, Chief R&D Officer | |
|
| 14 Mar 2018 | 2018 Investor Day WEBCAST, HTL0018318 for DLB in Japan by Dr Tim Tasker, CMO | |
|
| 2 Feb 2018 | Corporate Profile Half Year Ended 30 Sep 2017 | |
|
| 8 Jan 2018 | 36th Annual J.P. Morgan Healthcare Conference | |
|
| 9 Nov 2017 | FY2017 Q2 Results Presentation | |
|
| 3 Jul 2017 | Corporate Presentation July 2017 | |
|
| 22 Jun 2017 | 27th Ordinary General Meeting of Shareholders | |
|
| 22 May 2017 | Individual Investor Day 2017 | |
|
| 12 May 2017 | FY2016 Full Year Results Presentation | |
|
| 15 Nov 2016 | FY2016 Q2 Results Presentation | |
|
| 24 Jun 2016 | 26th Ordinary General Meeting of Shareholders | |
|
| 16 May 2016 | FY2015 Full Year Results Presentation | |
|
| 12 Nov 2015 | FY2015 Q2 Results Presentation | |
|
| 24 Jun 2015 | R&D Day Presentation | ||
| 14 May 2015 | Investor Day Presentation | |
|
| 13 May 2015 | FY2014 Results Presentation | |
|